Accueil   Diary - News   All news Theranexus raises approximately € 2.2 million in a placement reserved to a category of persons

Theranexus raises approximately € 2.2 million in a placement reserved to a category of persons

 

Lyon, 11th July 2019 (8:50am CEST) – THERANEXUS (FR0013286259 – ALTHX / Eligible PEA/PME – the “Company”), innovative biopharmaceutical company involved in the treatment of neurological diseases and pioneer in the development of drug candidates acting on the interaction between neurons and glial cells, announces today the completion of a placement reserved for a certain category of persons via accelerated book building process for an amount of approx. EUR 2.2 million.

 

Read the press release